The efficiency of interferon therapy for acute respiratory viral infections in young children

The efficiency of interferon therapy for acute respiratory viral infections in young children

The problem of choosing an effective etiotropic treatment for acute respiratory viral infections in young children is one of the urgent in pediatrics.Materials and methods. The article presents data on the mechanism of the combined antiviral and immunomodulating action of the drug recombinant interf...

Full description

Bibliographic Details
Main Authors:	T. K. Chudakova, E. V. Mikhaylova
Format:	Article
Language:	Russian
Published:	LLC "Diagnostics and Vaccines" 2020-03-01
Series:	Детские инфекции (Москва)
Subjects:	acute respiratory viral infections children antiviral therapy interferon alfa-2b viferon®
Online Access:	https://detinf.elpub.ru/jour/article/view/476

Similar Items

The effectiveness of the use of the drug recombinant interferon alfa-2b for the prevention of acute respiratory infections in preschool children
by: S. A. Drakina, et al.
Published: (2019-12-01)

MODERN OPPORTUNITIES OF INTERFERON THERAPY AT INFLUENZA AND ACUTE RESPIRATORY INFECTIONS IN CHILDREN
by: T. A. Chebotareva, et al.
Published: (2015-08-01)

IMMUNOPATHOGENESIS OF ACUTE RESPIRATORY INFECTIONS AND TACTICS OF RATIONAL CHOICE OF ETIOTROPIC IMMUNOMODULATORY THERAPIES IN CHILDREN
by: V. V. Malinovskaya, et al.
Published: (2015-08-01)

ETIOTROPIC THERAPY FOR ACUTE RESPIRATORY VIRAL INFECTIONS WITH STENOSING LARYNGOTRACHEITIS
by: V. N. Timchenko, et al.
Published: (2018-07-01)

Еxternal forms of recombinant interferon alfa-2b - ointment and gel in the treatment of acute respiratory viral infections and influenza in children
by: O. V. Shamsheva, et al.
Published: (2020-06-01)

CLINICAL AND IMMUNOLOGICAL EFFICACY OF THE RECOMBINANT INTERFERON alfa-2b OF ACUTE EPSTEIN-BARR VIRAL MONONUCLEOSIS IN PRESCHOOL CHILDREN
by: V. N. Timchenko, et al.
Published: (2016-09-01)

RECURRENT RESPIRATORY INFECTIONS IN CHILDREN AND THE PROGRAM IMMUNOREHABILITATION
by: Т. A. Chebotareva, et al.
Published: (2015-08-01)

Evaluation of preventive effects of interferon inducer against acute respiratory viral infections in young people
by: E. P. Tikhonova, et al.
Published: (2021-06-01)

The Value of the Interferon Inductors in the Treatment and Prevention of Respiratory Infections
by: O. V. Kladova, et al.
Published: (2016-11-01)

OPTIMIZATION OF THE THERAPY OF ACUTE RESPIRATORY VIRAL INFECTIONS IN CHILDREN IN WEST-KAZAKHSTAN
by: A. N. Seipenova, et al.
Published: (2015-08-01)

Antiviral therapy of acute respiratory viral infection and influenza in children in a hospital
by: E. V. Sharipova, et al.
Published: (2018-12-01)

THERAPY OPTIMIZATION OF INFLUENZA AND OTHER ACUTE RESPIRATORY VIRAL INFECTIONS IN PEDIATRIC PRACTICE
by: G. P. Martynova, et al.
Published: (2012-04-01)

Use of interferon in prevention and treatment of respiratory viral infections in adults and children
by: N. D. Yuschuk, et al.
Published: (2021-06-01)

Clinical and epidemiologic efficacy of late interferon inductor in in the prevention of acute respiratory viral infections and influenza in 2017–2018 pre-epidemic period
by: V. A. Petrov, et al.
Published: (2021-06-01)

The use in pediatrics of recombinant interferon alfa-2b preparations in the dosage form rectal suppositories: whom? when? which ones?
by: M. S. Savenkova, et al.
Published: (2021-04-01)

BACTERIAL PURULENT MENINGITIS TREATMENT TACTICS OPTIMIZATION
by: L. N. Mazankova, et al.
Published: (2015-08-01)

Assessment of consumption of medicines of drugs in conditions of stationary treatment children with acute respiratory viral infections
by: I. A. Narkevich, et al.
Published: (2020-06-01)

Evaluation of the effectiveness and safety of interferon alpha-2b ointment and gel for prevention of acute respiratory infections in organized groups
by: K. V. Kozlov, et al.
Published: (2024-04-01)

Interferon lambda in respiratory viral infection: immunomodulatory functions and antiviral effects in epithelium
by: Yong-Guang Liu, et al.
Published: (2024-03-01)

Universal approaches to the treatment of acute respiratory viral infection and influenza
by: A. V. Mordyk, et al.
Published: (2023-08-01)

Respiratory viral infections in the lower respiratory tract failure (Literature review)
by: I. V. Babachenko, et al.
Published: (2021-12-01)

Elderly patient with acute respiratory viral infection
by: Leonid I. Dvoretsky
Published: (2023-01-01)

Comparative assessment of interferon activity in influenza and COVID-19
by: Tatiana P. Ospelnikova, et al.
Published: (2024-07-01)

Complex treatment of acute respiratory viral infections with bacterial exacerbation in preschool children
by: E. N. Ermakova, et al.
Published: (2021-09-01)

Cytokine status indicators in children with acute respiratory viral infections after treatment with intranasal interferon-based medicine
by: O. I. Afanasyeva, et al.
Published: (2021-12-01)

INTERFERON TREATMENT OF INFANTS WITH INTRAUTERINE INFECTIONS
by: O. V. Shamsheva, et al.
Published: (2015-08-01)

Comparative assessment of the effectiveness and safety of an interferon inducer in the complex treatment of viral respiratory tract Infections in children aged 3-18 years in real-world practice during the 2023-2024 respiratory disease season
by: M. S. Savenkova, et al.
Published: (2024-12-01)

Experience in the Treatment of Chronic Viral Hepatitis C in Children Born to HIV-positive Women
by: V. N. Timchenko, et al.
Published: (2015-12-01)

Risk factors that determine the severity of bronchial obstruction syndrome of acute respiratory viral infections in children
by: L. V. Kramar, et al.
Published: (2021-07-01)

Modern aspects of the therapy of acute respiratory viral infections (systematic review)
by: E. V. Esaulenko, et al.
Published: (2024-12-01)

Clinical efficiency and safety of riamilovir under various dosage regimens for treatment of acute respiratory viral infections in adults
by: Konstantin V. Zhdanov, et al.
Published: (2023-12-01)

Arrhythmias in Children with Acute Respiratory Viral Infections: Prevalence and Causes
by: Sabina Kh. Israfilova, et al.
Published: (2024-09-01)

On the Possibility of Using the Topical form of the Recombinant Interferon alpha-2b Drug in the Prevention of Acute Respiratory Viral Infections in Organized Groups
by: M. P. Kostinov, et al.
Published: (2024-05-01)

APPROACHES TO THE TREATMENT OF ACUTE RESPIRATORY INFECTIONS AND INFLUENZA DURING THE SEASONAL INCREASE IN THE INCIDENCE OF DISEASES
by: L. L. Nisevich, et al.
Published: (2015-02-01)

Peculiarities of children’s health status after acute respiratory viral infections: a look at the problem, ways to solve it
by: Yu.V. Marushko, et al.
Published: (2024-10-01)

Hemophagocytic syndrome in acute respiratory viral infections
by: M. V. Shipilov
Published: (2014-09-01)

CHARACTERISTICS OF THE CAUSATIVE AGENTS OF ACUTE RESPIRATORY VIRAL INFECTIONS AND THE IMPORTANCE OF DISINFECTION MEASURES IN PREVENTING THEIR SPREAD
by: L. V. Rubis
Published: (2018-04-01)

Deciphering Respiratory-Virus-Associated Interferon Signaling in COPD Airway Epithelium
by: Hong Guo-Parke, et al.
Published: (2022-01-01)

ESSENTIAL OILS INHALATIONS IN COMPLEX TREATMENT AND PROPHYLAXIS OF ACUTE RESPIRATORY VIRAL INFECTIONS IN CHILDREN
by: A. D. Petrushina, et al.
Published: (2012-03-01)

Evaluation of Eﬃcacy and Safety of Diﬀerent Doses of Eladis® in the Therapy of Cough Against Acute Respiratory Viral Infection
by: E. D. Volnaya, et al.
Published: (2024-10-01)